Intrinsiqq
Bio-Rad Laboratories Inc. logo

Bio-Rad Laboratories Inc. Insider Trading

BIO

⊜ Compare
Last 12 months

Insiders sold 350K and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. EVP, President, LSG James Barry sold 214K on Nov 6, 2025, 58% of their stake, outside a plan. The last open-market buy by an executive or director was in May 2017.

Net open-market
−350K
0 buys · 2 sales
Under a 10b5-1 plan
0%
of the value sold
Insiders who bought / sold
0 / 2
executives and directors
Last open-market buy
May 2017
May 26, 2017

Get an email when BIO's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • May 11No plan
    Eva Anette Engelhardt
    EVP, President, CDG · sold 550 at $246.54
    136K
    61% of stake
  • Nov 6, 2025No plan
    James Barry
    EVP, President, LSG · sold 700 at $306.18
    214K
    58% of stake
  • Mar 14, 2025No plan
    Michael Crowley
    EVP, GBL Commercial Operations · sold 3,000 at $247.06
    741K
    27% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch BIO, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Laboratory Analytical Instruments · Pick stocks to compare with BIO

CompareIntrinsic value
RVTYRevvity Inc.
$159.44-2.47%20
BRKRBruker Corporation
$63.79+12.90%23
WATWaters Corporation
$467.60+1.67%25
MTDMettler-Toledo International Inc.
$1,723.24+1.48%41
ILMNIllumina, Inc.
$226.54-4.90%68
TXG10x Genomics Inc.
$67.52+3.42%48
AVTRAvantor Inc.
$15.65+0.38%22
AAgilent Technologies Inc.
$177.17+0.97%44

Held by ETFs

BIO is in 117 US ETFs. The largest of them, with BIO's weight in each:

Spot a number that looks wrong? Check it in BIO's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing BIO

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.